100 related articles for article (PubMed ID: 1721812)
1. Mutants of human insulin-like growth factor II: expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62-67.
Roth BV; Bürgisser DM; Lüthi C; Humbel RE
Biochem Biophys Res Commun; 1991 Dec; 181(2):907-14. PubMed ID: 1721812
[TBL] [Abstract][Full Text] [Related]
2. Mutants of human insulin-like growth factor II (IGF II). Expression and characterization of truncated IGF II and of two naturally occurring variants.
Lüthi C; Roth BV; Humbel RE
Eur J Biochem; 1992 Apr; 205(2):483-90. PubMed ID: 1374027
[TBL] [Abstract][Full Text] [Related]
3. The design, expression, and characterization of human insulin-like growth factor II (IGF-II) mutants specific for either the IGF-II/cation-independent mannose 6-phosphate receptor or IGF-I receptor.
Sakano K; Enjoh T; Numata F; Fujiwara H; Marumoto Y; Higashihashi N; Sato Y; Perdue JF; Fujita-Yamaguchi Y
J Biol Chem; 1991 Nov; 266(31):20626-35. PubMed ID: 1657932
[TBL] [Abstract][Full Text] [Related]
4. Altered affinity of insulin-like growth factor II (IGF-II) for receptors and IGF-binding proteins, resulting from limited modifications of the IGF-II molecule.
Oh Y; Beukers MW; Pham HM; Smanik PA; Smith MC; Rosenfeld RG
Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):249-54. PubMed ID: 1715685
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.
Oh Y; Müller HL; Lee DY; Fielder PJ; Rosenfeld RG
Endocrinology; 1993 Mar; 132(3):1337-44. PubMed ID: 7679979
[TBL] [Abstract][Full Text] [Related]
6. A mutant of human insulin-like growth factor II (IGF II) with the processing sites of proinsulin. Expression and binding studies of processed IGF II.
Zarn JA; Lüthi C; Giger RJ; Sigrist A; Humbel RE
Eur J Biochem; 1992 Dec; 210(3):665-9. PubMed ID: 1282887
[TBL] [Abstract][Full Text] [Related]
7. N-terminal deletion mutants of insulin-like growth factor-II (IGF-II) show Thr7 and Leu8 important for binding to insulin and IGF-I receptors and Leu8 critical for all IGF-II functions.
Hashimoto R; Fujiwara H; Higashihashi N; Enjoh-Kimura T; Terasawa H; Fujita-Yamaguchi Y; Inagaki F; Perdue JF; Sakano K
J Biol Chem; 1995 Jul; 270(30):18013-8. PubMed ID: 7629109
[TBL] [Abstract][Full Text] [Related]
8. Mutants of human insulin-like growth factor II with altered affinities for the type 1 and type 2 insulin-like growth factor receptor.
Bürgisser DM; Roth BV; Giger R; Lüthi C; Weigl S; Zarn J; Humbel RE
J Biol Chem; 1991 Jan; 266(2):1029-33. PubMed ID: 1845984
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells.
Neely EK; Rosenfeld RG
Endocrinology; 1992 Feb; 130(2):985-93. PubMed ID: 1370799
[TBL] [Abstract][Full Text] [Related]
10. [Leu27] insulin-like growth factor II is highly selective for the type-II IGF receptor in binding, cross-linking and thymidine incorporation experiments.
Beukers MW; Oh Y; Zhang H; Ling N; Rosenfeld RG
Endocrinology; 1991 Feb; 128(2):1201-3. PubMed ID: 1846582
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II.
Francis GL; Aplin SE; Milner SJ; McNeil KA; Ballard FJ; Wallace JC
Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):713-9. PubMed ID: 7688957
[TBL] [Abstract][Full Text] [Related]
12. Structural analogs of human insulin-like growth factor (IGF) I with altered affinity for type 2 IGF receptors.
Cascieri MA; Chicchi GG; Applebaum J; Green BG; Hayes NS; Bayne ML
J Biol Chem; 1989 Feb; 264(4):2199-202. PubMed ID: 2536701
[TBL] [Abstract][Full Text] [Related]
13. Mutations at positions 11 and 60 of insulin-like growth factor 1 reveal differences between its interactions with the type I insulin-like-growth-factor receptor and the insulin receptor.
Hodgson DR; May FE; Westley BR
Eur J Biochem; 1995 Oct; 233(1):299-309. PubMed ID: 7588759
[TBL] [Abstract][Full Text] [Related]
14. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency.
Francis GL; Ross M; Ballard FJ; Milner SJ; Senn C; McNeil KA; Wallace JC; King R; Wells JR
J Mol Endocrinol; 1992 Jun; 8(3):213-23. PubMed ID: 1378742
[TBL] [Abstract][Full Text] [Related]
15. Secretion of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 by intestinal epithelial (IEC-6) cells: implications for autocrine growth regulation.
Park JH; McCusker RH; Vanderhoof JA; Mohammadpour H; Harty RF; MacDonald RG
Endocrinology; 1992 Sep; 131(3):1359-68. PubMed ID: 1380441
[TBL] [Abstract][Full Text] [Related]
16. Expression, purification, and in vitro characterization of recombinant salmon insulin-like growth factor-II.
Wilkinson RJ; Elliott P; Carragher JF; Francis G
Protein Expr Purif; 2004 Jun; 35(2):334-43. PubMed ID: 15135411
[TBL] [Abstract][Full Text] [Related]
17. Production of biologically active recombinant tilapia insulin-like growth factor-II polypeptides in Escherichia coli cells and characterization of the genomic structure of the coding region.
Chen JY; Chang CY; Chen JC; Shen SC; Wu JL
DNA Cell Biol; 1997 Jul; 16(7):883-92. PubMed ID: 9260931
[TBL] [Abstract][Full Text] [Related]
18. Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts.
Bach LA; Salemi R; Leeding KS
Endocrinology; 1995 Nov; 136(11):5061-9. PubMed ID: 7588242
[TBL] [Abstract][Full Text] [Related]
19. Binding properties of chimeric insulin receptors containing the cysteine-rich domain of either the insulin-like growth factor I receptor or the insulin receptor related receptor.
Zhang B; Roth RA
Biochemistry; 1991 May; 30(21):5113-7. PubMed ID: 1645190
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of a unique high molecular weight form of insulin-like growth factor II.
Gowan LK; Hampton B; Hill DJ; Schlueter RJ; Perdue JF
Endocrinology; 1987 Aug; 121(2):449-58. PubMed ID: 2439316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
